Abstract
Advances in breast cancer treatment have markedly increased survivorship over the past three decades, with over 3.1 million survivors expected to live into their 70s and 80s. Without symptom relief interventions, nearly 35% of these survivors will have life-altering and distressing cognitive symptoms. This pilot study explored associations between serum markers of vascular aging, laterality in cerebral oxygenation, and severity of cognitive impairment in women, 12–18 months after chemotherapy for stage 2/3 invasive ductal breast cancer. Fifteen women (52–84 years) underwent a brief cognitive assessment (Montreal Cognitive Assessment [MOCA]) and blood draws to assess markers of vascular aging (interleukin-6 [IL-6], tumor necrosis factor alpha [TNF-α], C-reactive protein [CRP], and insulin growth factor-1 [IGF-1]). All underwent a computer-based test protocol that is known to increase blood flow within the frontal lobes. Percent cerebral oxyhemoglobin saturation (rcSO2) was recorded during and after testing. Laterality in rcSO2 was defined by ≥ 3% difference between left and right rcSO2 (|rcSO2 meanRIGHT – meanLEFT|). Eight participants had MOCA scores between 21 and 25 points, suggestive of mild cognitive impairment. Neither CRP (r = −.24) nor IL-6 (r = .34) nor TNF-α (r = .002) were associated with MOCA scores. Higher IL-6 was associated with greater laterality (r = .41). MOCA scores were significantly lower in subjects with laterality in rcSO2 than in those without laterality (F(1,14) = 13.5, p = 003). Lower IGF-1 was significantly associated with greater laterality (r = − .66, p = .007) and lower cognitive function (r = .58). These findings suggest that persistent cognitive impairment is associated with phenotypical changes consistent with accelerated vascular aging.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Acaz-Fonseca E, Sanchez-Gonzalez R, Azcoitia I, Arevalo MA, Garcia-Segura LM (2014) Role of astrocytes in the neuroprotective actions of 17beta-estradiol and selective estrogen receptor modulators. Mol Cell Endocrinol 389:48–57. https://doi.org/10.1016/j.mce.2014.01.009
Ahles TA, Saykin A (2001) Cognitive effects of standard-dose chemotherapy in patients with cancer. Cancer Investig 19:812–820
Ahles TA, Saykin AJ, McDonald BC, Li Y, Furstenberg CT, Hanscom BS, Mulrooney TJ, Schwartz GN, Kaufman PA (2010) Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol 28:4434–4440. https://doi.org/10.1200/JCO.2009.27.0827
Al-Kindi SG, Oliveira GH (2016) Prevalence of preexisting cardiovascualr disease in patiehts with different types of cancer: the unmet need for onco-cardiology. Mayo Clin Proc 91:81–83. https://doi.org/10.1016/j.mayocp.2015.09.009
Boykoff N, Moieni M, Subramanian SK (2009) Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response. J Cancer Surviv 3:223–232. https://doi.org/10.1007/s11764-009-0098-x
Calderon-Arnulphi M, Alaraj A, Amin-Hanjani S, Mantulin WW, Polzonetti CM, Gratton E, Charbel FT (2007) Detection of cerebral ischemia in neurovascular surgery using quantitative frequency-domain near-infrared spectroscopy. J Neurosurg 106:283–290. https://doi.org/10.3171/jns.2007.106.2.283
Cardona-Gomez GP, Mendez P, DonCarlos LL, Azcoitia I, Garcia-Segura LM (2001) Interactions of estrogens and insulin-like growth factor-I in the brain: implications for neuroprotection. Brain Res Brain Res Rev 37:320–334
Che W, Lerner-Marmarosh N, Huang Q, Osawa M, Ohta S, Yoshizumi M, Glassman M, Lee JD, Yan C, Berk BC, Abe J (2002) Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: role of Gab1 and MEKK3 in TNF-alpha-induced c-Jun and NF-kappaB activation and adhesion molecule expression. Circ Res 90:1222–1230
Christopoulos PF, Msaouel P, Koutsilieris M (2015) The role of the insulin-like growth factor-1 system in breast cancer. Mol Cancer 14:43. https://doi.org/10.1186/s12943-015-0291-7
Csiszar A, Sosnowska D, Wang M, Lakatta EG, Sonntag WE, Ungvari Z (2012) Age-associated proinflammatory secretory phenotype in vascular smooth muscle cells from the non-human primate Macaca mulatta: reversal by resveratrol treatment. J Gerontol A Biol Sci Med Sci 67:811–820. https://doi.org/10.1093/gerona/glr228
Di Lisi D et al (2017) Anticancer therapy-induced vascular toxicity: VEGF inhibition and beyond. Int J Cardiol 227:11–17. https://doi.org/10.1016/j.ijcard.2016.11.174
Di Marco LY, Farkas E, Martin C, Venneri A, Frangi AF (2015) Is Vasomotion in cerebral arteries impaired in Alzheimer’s disease? J Alzheimers Dis 46:35–53. https://doi.org/10.3233/JAD-142976
Dyer AH, Vahdatpour C, Sanfeliu A, Tropea D (2016) The role of insulin-like growth factor 1 (IGF-1) in brain development, maturation and neuroplasticity. Neuroscience 325:89–99. https://doi.org/10.1016/j.neuroscience.2016.03.056
Falleti MG, Maruff P, Burman P, Harris A (2006) The effects of growth hormone (GH) deficiency and GH replacement on cognitive performance in adults: a meta-analysis of the current literature. Psychoneuroendocrinology 31:681–691. https://doi.org/10.1016/j.psyneuen.2006.01.005
Hawsawi Y, El-Gendy R, Twelves C, Speirs V, Beattie J (2013) Insulin-like growth factor - oestradiol crosstalk and mammary gland tumourigenesis. Biochim Biophys Acta 1836:345–353. https://doi.org/10.1016/j.bbcan.2013.10.005
Hirth C, Obrig H, Valdueza J, Dirnagl U, Villringer A (1997) Simultaneous assessment of cerebral oxygenation and hemodynamics during a motor task. A combined near infrared and transcranial Doppler sonography study. Adv Exp Med Biol 411:461–469
Holohan KN, Von Ah D, McDonald BC, Saykin AJ (2013) Neuroimaging, cancer, and cognition: state of the knowledge. Semin Oncol Nurs 29:280–287. https://doi.org/10.1016/j.soncn.2013.08.008
Irwan YY, Feng Y, Gach HM, Symanowski JT, McGregor JR, Veni G, Schabel M, Samlowski WE (2009) Quantitative analysis of cytokine-induced vascular toxicity and vascular leak in the mouse brain. J Immunol Methods 349:45–55. https://doi.org/10.1016/j.jim.2009.07.014
Janelsins MC, Mustian KM, Palesh OG, Mohile SG, Peppone LJ, Sprod LK, Heckler CE, Roscoe JA, Katz AW, Williams JP, Morrow GR (2012) Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research. Support Care Cancer 20:831–839. https://doi.org/10.1007/s00520-011-1158-0
Jonsson M, Lindstrom D, Wanhainen A, Djavani Gidlund K, Gillgren P (2017) Near infrared spectroscopy as a predictor for shunt requirement during carotid endarterectomy. Eur J Vasc Endovasc Surg 53:783–791. https://doi.org/10.1016/j.ejvs.2017.02.033
Koppelmans V, Breteler MM, Boogerd W, Seynaeve C, Gundy C, Schagen SB (2012) Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. J Clin Oncol 30:1080–1086. https://doi.org/10.1200/JCO.2011.37.0189
Lyon DE, Cohen R, Chen H, Kelly DL, McCain NL, Starkweather A, Ahn H, Sturgill J, Jackson-Cook CK (2016) Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer. J Neuroimmunol 301:74–82. https://doi.org/10.1016/j.jneuroim.2016.11.002
Madsen PL, Secher NH (1999) Near-infrared oximetry of the brain. Prog Neurobiol 58:541–560
Mason PF, Dyson EH, Sellars V, Beard JD (1994) The assessment of cerebral oxygenation during carotid endarterectomy utilising near infrared spectroscopy. Eur J Vasc Surg 8:590–594
McDonald BC, Saykin AJ (2013) Alterations in brain structure related to breast cancer and its treatment: chemotherapy and other considerations. Brain Imaging Behav 7:374–387. https://doi.org/10.1007/s11682-013-9256-x
Meeker CR, Wong YN, Egleston BL, Hall MJ, Plimack ER, Martin LP, von Mehren M, Lewis BR, Geynisman DM (2017) Distress and financial distress in adults with cancer: an age-based analysis. J Natl Compr Cancer Netw 15:1224–1233. https://doi.org/10.6004/jnccn.2017.0161
Mehagnoul-Schipper DJ, van der Kallen BFW, Colier WNJM, van der Sluijs MC, van Erning LJTO, Thijssen HOM, Oeseburg B, Hoefnagels WHL, Jansen RWMM (2002) Simultaneous measurements of cerebral oxygenation changes during brain activation by near-infrared spectroscopy and functional magnetic resonance imaging in healthy young and elderly subjects. Hum Brain Mapp 16:14–23
Myers JS (2012) Chemotherapy-related cognitive impairment: the breast cancer experience. Oncol Nurs Forum 39:E31–E40. https://doi.org/10.1188/12.ONF.E31-E40
Nasreddine ZS, Phillips NA, Bédirian Vé, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.x
Nguyen CM, Yamada TH, Beglinger LJ, Cavanaugh JE, Denburg NL, Schultz SK (2013) Cognitive features 10 or more years after successful breast cancer survival: comparisons across types of cancer interventions. Psychooncology 22:862–868. https://doi.org/10.1002/pon.3086
Park HM, Kim TW, Choi HG, Yoon KB, Yoon DM (2010) The change in regional cerebral oxygen saturation after stellate ganglion block. Korean J Pain 23:142–146. https://doi.org/10.3344/kjp.2010.23.2.142
Petersen RC, Caracciolo B, Brayne C, Gauthier S, Jelic V, Fratiglioni L (2014) Mild cognitive impairment: a concept in evolution. J Intern Med 275:214–228. https://doi.org/10.1111/joim.12190
Pollard V, Prough DS, DeMelo AE, Deyo DJ, Uchida T, Stoddart HF (1996) Validation in volunteers of a near-infrared spectroscope for monitoring brain oxygenation in vivo. Anesth Analg 82:269–277
Soultati A, Mountzios G, Avgerinou C, Papaxoinis G, Pectasides D, Dimopoulos MA, Papadimitriou C (2012) Endothelial vascular toxicity from chemotherapeutic agents: preclinical evidence and clinical implications. Cancer Treat Rev 38:473–483. https://doi.org/10.1016/j.ctrv.2011.09.002
Starkweather A, Kelly DL, Thacker L, Wright ML, Jackson-Cook CK, Lyon DE (2017) Relationships among psychoneurological symptoms and levels of C-reactive protein over 2 years in women with early-stage breast cancer. Support Care Cancer 25:167–176. https://doi.org/10.1007/s00520-016-3400-2
Tarantini S, Valcarcel-Ares NM, Yabluchanskiy A, Springo Z, Fulop GA, Ashpole N, Gautam T, Giles CB, Wren JD, Sonntag WE, Csiszar A, Ungvari Z (2017) Insulin-like growth factor 1 deficiency exacerbates hypertension-induced cerebral microhemorrhages in mice, mimicking the aging phenotype. Aging Cell 16:469–479. https://doi.org/10.1111/acel.12583
Toth P, Tucsek Z, Tarantini S, Sosnowska D, Gautam T, Mitschelen M, Koller A, Sonntag WE, Csiszar A, Ungvari Z (2014) IGF-1 deficiency impairs cerebral myogenic autoregulation in hypertensive mice. J Cereb Blood Flow Metab 34:1887–1897. https://doi.org/10.1038/jcbfm.2014.156
Toth P, Tarantini S, Ashpole NM, Tucsek Z, Milne GL, Valcarcel-Ares NM, Menyhart A, Farkas E, Sonntag WE, Csiszar A, Ungvari Z (2015) IGF-1 deficiency impairs neurovascular coupling in mice: implications for cerebromicrovascular aging. Aging Cell 14:1034–1044. https://doi.org/10.1111/acel.12372
Trzepacz PT, Hochstetler H, Wang S, Walker B, Saykin AJ et al (2015) Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults. BMC Geriatr 15:107. https://doi.org/10.1186/s12877-015-0103-3
Tsavaris N, Kosmas C, Vadiaka M, Kanelopoulos P, Boulamatsis D (2002) Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes. Br J Cancer 87:21–27. https://doi.org/10.1038/sj.bjc.6600347
Tsoi KK, Chan JY, Hirai HW, Wong SY, Kwok TC (2015) Cognitive tests to detect dementia: a systematic review and meta-analysis. JAMA Intern Med 175:1450–1458. https://doi.org/10.1001/jamainternmed.2015.2152
Ungvari Z, Kaley G, de Cabo R, Sonntag WE, Csiszar A (2010) Mechanisms of vascular aging: new perspectives. J Gerontol A Biol Sci Med Sci 65:1028–1041. https://doi.org/10.1093/gerona/glq113
Von Ah D, Tallman EF (2015) Perceived cognitive function in breast cancer survivors: evaluating relationships with objective cognitive performance and other symptoms using the functional assessment of cancer therapy-cognitive function instrument. J Pain Symptom Manag 49:697–706. https://doi.org/10.1016/j.jpainsymman.2014.08.012
Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjogren M et al (2001) A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32:1318–1322. https://doi.org/10.1161/01.STR.32.6.1318
Wefel JS, Saleeba AK, Buzdar AU, Meyers CA (2010) Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer 116:3348–3356. https://doi.org/10.1002/cncr.25098
Wenger MK, Negash S, Petersen RC, Petersen L (2010) Modeling and estimating recall processing capacity: sensitivity and diagnostic utility in application to mild cognitive impairment. J Math Psychol 54:73–89. https://doi.org/10.1016/j.jmp.2009.04.012
White LR, Edland SD, Hemmy LS, Montine KS, Zarow C, Sonnen JA, Uyehara-Lock JH, Gelber RP, Ross GW, Petrovitch H, Masaki KH, Lim KO, Launer LJ, Montine TJ (2016) Neuropathologic comorbidity and cognitive impairment in the Nun and Honolulu-Asia Aging Studies. Neurology 86(11):1000–1008
Yeh ET (2005) High-sensitivity C-reactive protein as a risk assessment tool for cardiovascular disease. Clin Cardiol 28:408–412
Zhang X, Toronov VY, Fabiani M, Gratton G, Webb AG (2005) The study of cerebral hemodynamic and neuronal response to visual stimulation using simultaneous NIR optical tomography and BOLD fMRI in humans. Proc SPIE Int Soc Opt Eng 5686:566–572. https://doi.org/10.1117/12.593435
Acknowledgements
This work was funded by a grant from the Donald W. Reynolds Foundation to MAC. We also wish to thank Elangovan Thavathiru, Ph.D. for the processing and analyses of the samples.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Carlson, B.W., Craft, M.A., Carlson, J.R. et al. Accelerated vascular aging and persistent cognitive impairment in older female breast cancer survivors. GeroScience 40, 325–336 (2018). https://doi.org/10.1007/s11357-018-0025-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11357-018-0025-z